Intriguingly, KEAP1 has been identified as a sorafenib/mTKI sensitivity gene in HCC [18], yet the mechanism underlying KEAP1 loss in sorafenib resistance remains elusive. Here, KEAP1 is linked to hepatocellular carcinoma.